Profile data is unavailable for this security.
About the company
Sonoma Pharmaceuticals, Inc. is a global healthcare company, which is engaged in developing and producing stabilized hypochlorous acid (HOCl), products for a range of applications, including wound care, eye care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. The Company's product offerings include Lumacyn Clarifying Mist; Regenacyn Advanced Scar Gel; Reliefacyn Advanced Itch-Burn-Rash-Pain Relief Hydrogel; Microcyn OTC Advanced Wound & Skin Cleanser; Podiacyn Advanced Everyday Foot Care, MicrocynAH and others. Lumacyn Clarifying Mist is intended for use as a daily skin toner, to soothe and cleanse the skin, reduce redness, and manage blemishes by reducing infection. Podiacyn is intended for management of foot odors, infections, and irritations, as well as daily foot health and hygiene. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a range of animal wounds and infections.
- Revenue in USD (TTM)12.74m
- Net income in USD-4.84m
- Incorporated2006
- Employees172.00
- LocationSonoma Pharmaceuticals Inc5445 CONESTOGA COURT, SUITE 150BOULDER 80301United StatesUSA
- Phone+1 (617) 243-0050
- Fax+1 (707) 283-0551
- Websitehttps://sonomapharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Evoke Pharma Inc | 6.11m | -7.13m | 4.64m | 4.00 | -- | 1.33 | -- | 0.7604 | -1.83 | -1.83 | 1.28 | 0.4068 | 0.5429 | 0.5113 | 5.71 | 1,526,428.00 | -63.39 | -100.48 | -76.67 | -151.10 | 96.01 | -- | -116.76 | -480.52 | 5.35 | -19.25 | 0.5884 | -- | 106.51 | -- | 5.25 | -- | -- | -- |
| Titan Pharmaceuticals Inc | 87.00k | -4.95m | 4.71m | 4.00 | -- | 0.7736 | -- | 54.12 | -6.41 | -6.41 | 0.1119 | 6.66 | 0.0197 | -- | 1.23 | 21,750.00 | -112.41 | -96.80 | -170.59 | -156.65 | -- | -- | -5,694.25 | -406.26 | -- | -415.19 | 0.00 | -- | -66.97 | -51.16 | 45.43 | -- | -65.61 | -- |
| Processa Pharmaceuticals Inc | 0.00 | -9.83m | 4.94m | 13.00 | -- | 0.5562 | -- | -- | -6.29 | -6.29 | 0.00 | 3.11 | 0.00 | -- | -- | 0.00 | -87.82 | -84.35 | -102.32 | -90.03 | -- | -- | -- | -- | -- | -- | 0.0012 | -- | -- | -- | 59.45 | -- | -34.05 | -- |
| Hanyuan Biotech International Inc | 10.65m | 3.14m | 5.28m | -- | 0.0294 | 0.0064 | 1.45 | 0.4957 | 0.2246 | 0.2246 | 0.7611 | 1.03 | -- | -- | -- | -- | -- | -- | -- | -- | 68.54 | -- | 29.51 | -- | 13.36 | 25.66 | 0.00 | -- | 50.51 | -- | 106.71 | -- | -- | -- |
| Stemtech Corp | 4.64m | -4.08m | 5.63m | 45.00 | -- | -- | -- | 1.21 | -0.0624 | -0.0624 | 0.0619 | -0.0092 | 1.09 | 8.35 | 65.16 | 103,098.40 | -96.70 | -- | -- | -- | 76.09 | -- | -88.58 | -- | 0.1045 | -1.81 | 2.27 | -- | -- | -- | -- | -- | -- | -- |
| SYBLEU Inc | 11.70k | -307.88k | 5.92m | -- | -- | -- | -- | 505.72 | -0.0293 | -0.0293 | 0.0011 | -0.0367 | 0.0641 | -- | -- | -- | -168.63 | -- | -- | -- | -- | -- | -2,631.45 | -- | -- | -8.48 | 4.96 | -- | 0.00 | -- | 26.51 | -- | -- | -- |
| Integrated BioPharma, Inc. | 50.57m | -116.00k | 6.02m | 141.00 | -- | 0.3183 | 28.40 | 0.119 | -0.0041 | -0.0041 | 1.67 | 0.6283 | 1.88 | 4.45 | 10.76 | 358,617.00 | -0.431 | 15.51 | -0.5698 | 27.94 | 7.09 | 12.09 | -0.2294 | 6.44 | 1.02 | -9.00 | 0.001 | -- | -9.91 | 3.00 | -101.35 | -- | -14.03 | -- |
| GT Biopharma Inc | 0.00 | -9.64m | 6.21m | 2.00 | -- | 0.7487 | -- | -- | -7.04 | -7.04 | 0.00 | 3.85 | 0.00 | -- | -- | 0.00 | -64.24 | -205.36 | -90.39 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 63.62 | -- | -- | -- |
| Sunshine Biopharma Inc | 26.74m | -4.09m | 6.50m | 44.00 | -- | 0.0138 | -- | 0.243 | -13.35 | -13.35 | 76.96 | 24.96 | 0.9081 | 3.13 | 11.58 | 607,722.50 | -13.88 | -101.52 | -17.99 | -137.04 | 33.15 | 35.47 | -15.29 | -165.33 | 3.23 | -- | 0.00 | -- | 454.42 | -- | 83.15 | -- | 110.99 | -- |
| Shuttle Pharmaceuticals Holdings Inc | 0.00 | -7.35m | 6.53m | 8.00 | -- | 2.37 | -- | -- | -0.4739 | -0.4739 | 0.00 | 0.1642 | 0.00 | -- | -- | 0.00 | -96.75 | -- | -119.37 | -- | -- | -- | -- | -- | -- | -5.28 | 0.2542 | -- | -- | -- | -112.71 | -- | -- | -- |
| Sonoma Pharmaceuticals Inc | 12.74m | -4.84m | 6.84m | 172.00 | -- | 0.9153 | -- | 0.5371 | -0.7237 | -0.7237 | 1.40 | 0.3932 | 0.8224 | 2.87 | 4.66 | 74,040.70 | -31.22 | -29.36 | -41.09 | -40.65 | 37.26 | 38.00 | -37.97 | -30.93 | 2.64 | -- | 0.05 | -- | -4.05 | -7.66 | 6.13 | -- | -29.84 | -- |
| Cannapharmarx Inc | 25.84k | -6.61m | 7.29m | 21.00 | -- | -- | -- | 282.02 | -0.0205 | -0.0205 | 0.00008 | -0.0425 | 0.0031 | -- | 0.4503 | 1,230.48 | -79.52 | -131.06 | -- | -- | -1,692.76 | -- | -25,598.30 | -- | 0.0033 | -0.1306 | -- | -- | -- | -- | 143.24 | -- | -- | -- |
| Healthy Extracts Inc | 2.56m | -2.76m | 7.41m | -- | -- | 48.86 | -- | 2.89 | -0.9512 | -0.9512 | 0.8819 | 0.0512 | 0.9428 | 0.5035 | 32.10 | -- | -101.47 | -53.78 | -375.65 | -146.65 | 68.46 | 45.68 | -107.63 | -87.53 | 0.1293 | -2.22 | 0.879 | -- | 10.41 | 105.93 | -151.54 | -- | -- | -- |
| Cadrenal Therapeutics Inc | -100.00bn | -100.00bn | 7.41m | 3.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Tonix Pharmaceuticals Holding Corp | 10.25m | -98.59m | 7.87m | 103.00 | -- | 0.017 | -- | 0.7675 | -177.41 | -177.41 | 9.46 | 46.94 | 0.0652 | -- | -- | 99,514.56 | -62.71 | -59.46 | -70.20 | -65.92 | 37.55 | -- | -961.87 | -5,126.73 | 0.8666 | -- | 0.0767 | -- | -- | -- | 0.1874 | -- | 320.57 | -- |
| Lotus Pharmaceuticals Inc | 70.79m | 1.72m | 8.89m | 233.00 | 0.0596 | 0.0009 | 2.30 | 0.1256 | 0.0553 | 0.0553 | 2.56 | 3.58 | 0.6321 | 37.27 | 17.85 | 303,836.90 | 1.55 | 22.84 | 1.71 | 26.40 | 35.10 | 41.62 | 2.45 | 19.93 | 0.4428 | 30.80 | 0.0516 | 0.00 | 28.71 | 31.70 | -12.22 | 51.11 | 70.48 | -- |
Data as of Jul 05 2024. Currency figures normalised to Sonoma Pharmaceuticals Inc's reporting currency: US Dollar USD
1.05%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| G1 Execution Services LLCas of 31 Mar 2024 | 46.05k | 0.30% |
| Geode Capital Management LLCas of 31 Mar 2024 | 35.78k | 0.23% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 24.32k | 0.16% |
| XTX Markets LLCas of 31 Mar 2024 | 16.46k | 0.11% |
| Two Sigma Securities LLCas of 31 Mar 2024 | 13.47k | 0.09% |
| Millennium Management LLCas of 31 Mar 2024 | 13.02k | 0.08% |
| Tower Research Capital LLCas of 31 Mar 2024 | 11.98k | 0.08% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 2.27k | 0.02% |
| U.S. Bank NA (Cincinnati Ohio Investment Management)as of 31 Mar 2024 | 500.00 | 0.00% |
| Wells Fargo Bank, NA (Private Banking)as of 31 Mar 2024 | 122.00 | 0.00% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
